RhineGene is an innovative biotechnology company aiming to be a supporter of healthcare professionals in providing high-quality care for the detection and diagnosis of various diseases and achieving the best outcomes for patients.
Founded in 2022 in the Netherlands, the company brings high-quality molecular diagnostic products to professionals worldwide and continues its sales activities on the international stage with its subsidiaries in the Philippines, Bulgaria, Poland, and Germany.
RhineGene offers a wide range of products with a portfolio including Real-Time PCR kits, nucleic acid extraction kits, Real-Time PCR instruments, and automated nucleic acid extraction robots. The company’s mission is to stand by patients, improve their lives, protect public health, and support healthcare professionals throughout these processes.
